Clin Transl Oncol 2020 Jan 31
SEOM clinical guideline thyroid cancer (2019).
Gallardo E, Medina J, Sánchez JC, Viúdez A, Grande E, Porras I, Ramón Y Cajal T, Trigo J, Iglesias L, Capdevila J
Thyroid carcinoma is the most frequent endocrine malignancy and accounts for around 3% of global cancer incidence. Different histologies and clinical ...
Read More
Source: PubMed
Mol. Cell. Biochem. 2020 Jan 31
Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer.
Guo Y, Liang F, Zhao F, Zhao J
Increasing evidence confirmed that the Warburg effect plays an important role involved in the progression of malignant tumors. Resibufogenin (RES) has ...
Read More
Source: PubMed
Cell Oncol (Dordr) 2020 Jan 31
FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C, Lin X, Wang Y, Liu X, Xiao Y, Liu J, Snijders AM, Wei G, Mao JH, Zhang P
FAM83D has been proposed to act as an oncoprotein in several types of human cancer. Its role and mode of action in human non-small cell lung cancer (N ...
Read More
Source: PubMed
Oncogene 2020 Jan 31
SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
He J, Zhou M, Li X, Gu S, Cao Y, Xing T, Chen W, Chu C, Gu F, Zhou J, Jin Y, Ma J, Ma D, Zou Q
Thyroid cancer is the fastest growing cancer among all solid tumors in recent decades. Papillary thyroid carcinoma (PTC) is the most predominant type ...
Read More
Source: PubMed
J Voice 2020 Jan 28
Preoperative Voice Characteristics in Thyroid Patients.
Viana Baptista SIR, Lott DG, Almeida SCC, Cid MO, Vera-Cruz PS, Zagalo C
Thyroid surgery outcomes have evolved from mortality control strategies to morbidity control measures. Most vocal outcomes research in thyroid surgery ...
Read More
Source: PubMed
